Rockefeller University
rockefeller.eduTotal trials
122
Active
6
Phase 3
2
Total enrollment
6,015
Read this sponsor's pipeline like an analyst.
Generate a written report: strategic focus, priority programs, pipeline shape, recent terminations and momentum, and the trials worth watching in the next 12 months.
~15-30 sec · cached for 24h
Pipeline matrix
Showing 2 of 2 active programs · click any cell for trials
| Intervention | Early Phase 1 | Phase 1 | Phase 2 | Phase 3 | Phase 4 | N/A | Total |
|---|---|---|---|---|---|---|---|
| HepB mAb19 | — | — | — | — | — | 1 | |
| Aspirin | — | — | — | — | — | 1 |
Next readouts
- 2026-11-01
- 2027-12-01
Top conditions
- Obesity19
- HIV Infections9
- Healthy Volunteers7
- Psoriasis7
- Human Immunodeficiency Virus6
- Healthy5
- Insulin Resistance4
- Atopic Dermatitis4
Frequently asked questions about Rockefeller University
- How many clinical trials does Rockefeller University have on ClinicalTrials.gov?
- Rockefeller University is listed as the lead sponsor on 122 clinical trials in ClinicalTrials.gov, 6 of which are currently active (recruiting, enrolling, or ongoing).
- How many of Rockefeller University's trials are in Phase 3?
- 2 of Rockefeller University's trials are in Phase 3, spread across 2 active drug programs.
- What therapeutic areas does Rockefeller University focus on?
- Rockefeller University's most-studied conditions on ClinicalTrials.gov are Obesity, HIV Infections, Healthy Volunteers, Psoriasis, Human Immunodeficiency Virus.
- When are Rockefeller University's next clinical trial readouts?
- Rockefeller University has 2 upcoming primary-completion readouts tracked here; the soonest is “Predictors of Aspirin Failure in Preeclampsia Prevention”, expected around 2026-11-01.